Login / Signup

International working group identifies need for newborn screening for mucopolysaccharidosis type I but states that existing hurdles must be overcome.

Rossella PariniAlexander BroomfieldMaureen A ClearyLinda De MeirleirMaja Di RoccoWaseem M FathallaNathalie GuffonChristina LampeAllan M LundMaurizio ScarpaAnna Tylki-SzymańskaJiří Zeman
Published in: Acta paediatrica (Oslo, Norway : 1992) (2018)
Newborn screening for mucopolysaccharidosis type I offers the potential for early diagnosis and early pre-symptomatic treatment, but existing hurdles need to be overcome.
Keyphrases
  • replacement therapy
  • smoking cessation
  • combination therapy
  • gene expression
  • human health